Get started
Author

Julie Ahsan Mackey

Observed names: J Mackey, J. Mackey, Julie Mackey
OpenAlex ID: A5111254162
Darbepoetin alfa administered every 3 weeks alleviates anaemia in patients with solid tumours receiving chemotherapy; results of a double-blind, placebo-controlled, randomised study
2003 · D. Kotasek, G. Steger, et al. · European Journal of Cancer · 139
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma
2024 · Thomas Witzig, Lubomir Sokol, et al. · Blood Advances · 15
P504: Updated Data for Ziftomenib in Patients With Npm1-mutated Relapsed or Refractory Acute Myeloid Leukemia
2023 · Amir Fathi, Eunice Wang, et al. · HemaSphere · 14
Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.
2009 · P Sève, J Mackey, et al. · PubMed · 5
Pb1885: Phase 1 Study of Ziftomenib in Combination With Venetoclax, Venetoclax/azacitidine, or Standard Induction (7 + 3) Chemotherapy in Patients With Acute Myeloid Leukemia
2023 · Amer M Zeidan, Amir Fathi, et al. · HemaSphere · 3
Beyond the Clinic Visit: Creation of a Heart Transplant and VAD Mentorship Program
2025 · W. Chiu, J. Mackey, et al. · The Journal of Heart and Lung Transplantation
PDF
Improving Compliance and Access to Nitroglycerin and Aspirin in People With Coronary Artery Disease: Development and Validation of the Smheartcard System
2018 · T. Le, J. Mackey, et al. · Canadian Journal of Cardiology
Works count: 7
Citation count: 176
H-index: 4
I10-index: 3
Year
Topic
Type